Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decryption of the retinoid death code in leukemia.

Lucia Altucci1, Hinrich Gronemeyer

  • 1Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, C U de Strasbourg, France. lucia.altucci@unina2.it

Journal of Clinical Immunology
|June 25, 2002
PubMed
Summary

Retinoids show promise for cancer therapy by inducing cancer cell death through novel pathways. These mechanisms involve tumor-selective ligands and distinct signaling routes, offering new avenues for treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Bisphenol A induces cell cycle arrest in primary and prostate cancer cells through EGFR/ERK/p53 signaling pathway activation.

Oncotarget·2026
Same author

Dynamic epigenetic regulation of BCLAF1 splicing in acute myeloid leukemia.

Cell death & disease·2026
Same author

Context-dependent effect of glucocorticoid receptor activity shapes ovarian cancer cell plasticity and therapy response.

Molecular cancer·2026
Same author

The role of OSM/OSMRβ axis in shaping the tumor microenvironment favoring MASLD-related HCC immune evasion.

Hepatology (Baltimore, Md.)·2026
Same author

UVI5008: the first reversible, non-covalent Bruton's tyrosine kinase epi-inhibitor for B-cell malignancies.

Journal of hematology & oncology·2026
Same author

Accessory microRNA byproducts expand RNA interference via microprocessor-mediated cleavage activation.

Science advances·2026

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Retinoids regulate crucial cellular processes including growth, differentiation, and apoptosis.
  • Their potential as anticancer drugs for therapy and prevention is significant.
  • Understanding retinoid signaling is key to developing new cancer treatments.

Purpose of the Study:

  • To elucidate novel molecular mechanisms by which retinoids induce cancer cell death.
  • To highlight the therapeutic promise of retinoids in cancer treatment and prevention.
  • To emphasize recently identified pathways controlling cancer cell proliferation.

Main Methods:

  • Identification of novel retinoid-induced signaling pathways.
  • Analysis of retinoid effects on acute promyelocytic leukemia (APL) cells.

Related Experiment Videos

  • Investigation of retinoic acid receptor (RAR) and retinoid X receptor (RXR) signaling.

    • Main Results:

    • Retinoids induce tumor-selective death ligand TRAIL, causing paracrine apoptosis in APL cells.
    • A novel RARalpha-independent cross-talk between rexinoids and PKA promotes APL cell maturation.
    • A distinct rexinoid pathway triggers apoptosis in immature APL cells, independent of RAR agonists.

    Conclusions:

    • Retinoids offer promising therapeutic strategies for cancer through multiple cell death pathways.
    • Novel RARalpha-independent and RXR-antagonized pathways contribute to retinoid's anticancer effects.
    • Further research into these mechanisms can optimize retinoid-based cancer therapies.